spacer
home > epc > winter 2017 > the lifecycle of a sample
PUBLICATIONS
European Pharmaceutical Contractor

The Lifecycle of a Sample

Research samples are invaluable scientific assets that support the foundation of new drug discovery and development. Studies suggest that standardised management of these materials can contribute to budget savings, cost avoidance and clinical trial efficiencies that could reduce drug development timelines. However, many organisations still employ a siloed approach where samples are scattered between multiple laboratories and testing facilities based on specific initiatives. This model presents numerous bottlenecks, such as delays in finding biological materials, extended distribution times and additional expenditure due to the lack of economies of scale. By taking a holistic approach to comprehensive sample management – in which every stage of the lifecycle is considered – a firm can maximise their inventories.

Establishing biospecimen collections to support clinical trials and future research requires strategic planning. Key elements in the process include providing sufficient funds to create and sustain the collection; adequate facilities and equipment to ensure they are secure; experienced staff, preservation and logistics management of biospecimens and their associated data; plus curation of all data parameters that will be needed to select specimens for use.

Financial resources are essential to create a quality biospecimen collection and to preserve it for future use. Budget planners must consider supporting all institutions involved in the collection, processing, analysis and storage of the samples during the active phases of the trial and after the primary study has ended. Centralising processing and repository activities can drastically reduce the cost of a trial by decreasing the number of institutions in which infrastructure must be maintained, and minimising transportion costs required by sites having to send samples to multiple labs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
As the Head of Global Operations for BioStorage Technologies, a Brooks Life Science Systems Company, Katheryn Shea is responsible for all operational aspects of the business across Asia, Europe and the US. She also provides technical leadership for specimen management, processing, storage and distribution activities and is instrumental in the development of business alliances and collaborations. Katheryn received her Bachelor of Science in Biology from St Mary’s College in Maryland, US, and is a well-published author on biological sample management best practices and regulations.
spacer
Katheryn Shea
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Positive results from first preclinical in-vivo studies of Affimer therapeutics


More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>

 
Industry Events

BioProcess International European Summit

25-26 April 2017, RAI, Amsterdam

BioProcess International European Summit is THE Bioprocessing event, bringing together 800+ attendees from all major departments in bioprocessing: Cell Culture, Downstream, Manufacturing, Vaccines, Viral Safety and Cell Line Development. Find out more: https://goo.gl/d64sXs
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement